New drug aims for better, safer sleep in the ICU
NCT ID NCT05913336
Summary
This study tested a new sedative medicine for adults in intensive care who need help breathing from a machine. The goal was to see if the drug could keep patients comfortably sedated for at least three days and allow them to wake up quickly when needed. Researchers measured how well it worked and checked for side effects in a small group of 24 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEDATION IN THE ICU are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, 550001, China
Conditions
Explore the condition pages connected to this study.